First New York Securities’s NEPHROGENEX INC COM NRX Stock Holding History

First New York Securities’s Portfolio NRX Stock Details NRX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2015 Q1	–	Sell	-1,000	Closed	-$13.3K	–	513
2014 Q4	$13.3K	Sell	1,000 -23,314	-96%	-$108K	0.02%	227
2014 Q3	$114K	Buy	+24,314	New	+$116K	0.08%	169
2014 Q2	–	Sell	-19,550	Closed	-$159K	–	447
2014 Q1	$159K	Buy	+19,550	New	+$199K	0.08%	163

Other funds holding NRX

RCP

Rho Capital Partners New York $20.4M AUM

VAM

Visium Asset Management New York $1.43B AUM 3.58% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Turner Investments Berwyn, Pennsylvania $134K AUM 49.03% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

BFA

BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return

UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

BIM

BlackRock Investment Management Wilmington, Delaware $86.4B AUM 16.83% 1-Year Est. Return

First New York Securities's NRX Position: Q1 2015 in Review

First New York Securities sold out of NEPHROGENEX INC COM (NRX) in Q1 2015, closing a stake of 1,000 shares — an estimated $13.3K sold.

First New York Securities first reported a position in NRX in Q1 2014 and held it in 3 quarters. The position peaked at $159K in Q1 2014. 13 funds tracked by Wall St. Rank hold NRX as of Q1 2015.

First New York Securities reported no remaining NEPHROGENEX INC COM position as of Q1 2015 after selling out during the quarter.
First New York Securities sold 1,000 NEPHROGENEX INC COM shares in Q1 2015, an estimated $13.3K.
First New York Securities first reported a position in NEPHROGENEX INC COM in Q1 2014 and held it in 3 quarters.
First New York Securities's NEPHROGENEX INC COM position peaked at $159K in Q1 2014.
13 funds tracked by Wall St. Rank held NEPHROGENEX INC COM as of Q1 2015.

Based on First New York Securities's 13F filing for Q1 2015, filed 6 May 2015.